I agree we are ahead of our time maybe a few years ago. The big pharmas know where the opportunities are.  Frankly COVID would have been nice and a revenue generator but it is all about piggy backing off the BTD. The recent news from Laval is quite amazing and further validation that Apabetalone will work. This is the make it or break it year, again. DM is lacking as the ideal fearless leader but with Eversana on board this will sort itself out in due course, good luck everyone . I thought this was dead money for the longest time and still think you need to bet on money you can't afford to lose. Having said that it is always that way in the Pharma industry until you have something that can't garner the Billions of cash available then you are no where. I think the science works just not the marketng chemistry for now so revenue is important the science is more so. I am probably wrong.